StockMacro
Company, fund or insider

Help

Menu

Lucid Diagnostics

$0.37 -66% in 6 monthsMarket cap $72.6M

LUCD on XNAS, Health Care, Lucid Diagnostics Inc., job postings

Measures activity, not value. Not investment advice.

Short interest hit 12.8M shares, 2.3 times a year earlier, while shares fell 63% in a year.

  • BadOne delisting notice filed in the last 90 days
  • BadNet loss of $48.5M over the last 12 months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
82
Website
luciddx.com
Listed
Nasdaq, US
Last results
12 Nov 2026
Next results
expected around 25 Mar 2027 (an estimate: a year ago it reported on 26 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.2M, net loss $6.7M.
Quarter to 31 Dec 2021: revenue $300K, net income -$11.3MQuarter to 31 Dec 2021: revenue $300K, net income -$11.3MQuarter to 31 Mar 2022: revenue $189K, net income -$12.3MQuarter to 31 Mar 2022: revenue $189K, net income -$12.3MQuarter to 30 Jun 2022: revenue –, net income -$14.6MQuarter to 30 Sep 2022: revenue $76K, net income -$14.3MQuarter to 30 Sep 2022: revenue $76K, net income -$14.3MQuarter to 31 Dec 2022: revenue $112K, net income -$14.9MQuarter to 31 Dec 2022: revenue $112K, net income -$14.9MQuarter to 31 Mar 2023: revenue $446K, net income -$16.2MQuarter to 31 Mar 2023: revenue $446K, net income -$16.2MQuarter to 30 Jun 2023: revenue $159K, net income -$11.4MQuarter to 30 Jun 2023: revenue $159K, net income -$11.4MQuarter to 30 Sep 2023: revenue $783K, net income -$14.2MQuarter to 30 Sep 2023: revenue $783K, net income -$14.2MQuarter to 31 Dec 2023: revenue $1.0M, net income -$10.8MQuarter to 31 Dec 2023: revenue $1.0M, net income -$10.8MQuarter to 31 Mar 2024: revenue $1.0M, net income -$10.6MQuarter to 31 Mar 2024: revenue $1.0M, net income -$10.6MQuarter to 30 Jun 2024: revenue $976K, net income -$11.0MQuarter to 30 Jun 2024: revenue $976K, net income -$11.0MQuarter to 30 Sep 2024: revenue $1.2M, net income -$12.4MQuarter to 30 Sep 2024: revenue $1.2M, net income -$12.4MQuarter to 31 Dec 2024: revenue $1.2M, net income -$11.5MQuarter to 31 Dec 2024: revenue $1.2M, net income -$11.5MQuarter to 31 Mar 2025: revenue $828K, net income -$26.9MQuarter to 31 Mar 2025: revenue $828K, net income -$26.9MQuarter to 30 Jun 2025: revenue $1.2M, net income -$4.4MQuarter to 30 Jun 2025: revenue $1.2M, net income -$4.4MQuarter to 30 Sep 2025: revenue $1.2M, net income -$10.4MQuarter to 30 Sep 2025: revenue $1.2M, net income -$10.4MQuarter to 31 Dec 2025: revenue $1.5M, net income -$16.3MQuarter to 31 Dec 2025: revenue $1.5M, net income -$16.3MQuarter to 31 Mar 2026: revenue $1.3M, net income -$13.9MQuarter to 31 Mar 2026: revenue $1.3M, net income -$13.9MQuarter to 30 Jun 2026: revenue $1.5M, net income -$11.7MQuarter to 30 Jun 2026: revenue $1.5M, net income -$11.7MQuarter to 30 Sep 2026: revenue $1.2M, net income -$6.7MQuarter to 30 Sep 2026: revenue $1.2M, net income -$6.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $26.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.2M-$6.7M
30 Jun 2026$1.5M-$11.7M
31 Mar 2026$1.3M-$13.9M
31 Dec 2025$1.5M-$16.3M
30 Sep 2025$1.2M-$10.4M
30 Jun 2025$1.2M-$4.4M
31 Mar 2025$828K-$26.9M
31 Dec 2024$1.2M-$11.5M
30 Sep 2024$1.2M-$12.4M
30 Jun 2024$976K-$11.0M
31 Mar 2024$1.0M-$10.6M
31 Dec 2023$1.0M-$10.8M
30 Sep 2023$783K-$14.2M
30 Jun 2023$159K-$11.4M
31 Mar 2023$446K-$16.2M
31 Dec 2022$112K-$14.9M
30 Sep 2022$76K-$14.3M
30 Jun 2022–-$14.6M
31 Mar 2022$189K-$12.3M
31 Dec 2021$300K-$11.3M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $5.4M $4.4M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +24% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$48.5M -$53.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. -16.5% – 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -942% – -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -893% – -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -306% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$51.8M –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $18.0M $47.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $17.3M $22.3M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$693K (net cash) -$25.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 2.9 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.03
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 14.2 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 14.1 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 13.0 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Lucid DiagnosticsLUCD (this company) $72.6Mloss14.2+24%-893%
SkinHealth SystemsSKIN $76.7Mloss0.27-4.4%-6.3%
LensarLNSR $54.8M–0.91+1.6%56.1%
Apyx MedicalAPYX $101.1Mloss1.7+24%-14.2%
PulmonxLUNG $111.9Mloss1.3-3.2%-47.9%
Microbot MedicalMBOT $45.7Mloss–––

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

0%

113 13F filers vs 113

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

29%

60.2M shares held by 13F filers (30 Sep 2026) of 207.0M outstanding (10 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.2%

15.0M shares sold short (30 Oct 2026) of 207.0M outstanding (10 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.0

15.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+9.9%

13.6M shares sold short in the report before, 15.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

64%

64% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

3

3 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

3.0×

3 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 12.8M, 2.3× a year earlier

Price $0.37 on 20 Nov 2026, -63% over 12 months (12-month range $0.33 to $1.47)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $245K in the last 12 months (the 12 months before: $560K).
Revenue per quarter. Revenue $1.2M in the latest quarter, -0.7% on a year earlier.
Capital spending per quarter. Capital spending $17K in the latest quarter, -39% on a year earlier.
Institutional holders (13F filers). 113 13F filers reported holding it in the latest 13F quarter, +43% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Oct 20268-K and other filingsDelisting notice or listing transfer
1 Sep 2026Sharp changeShort interest spike: short interest spike, 12.8M vs usual 5.9M (2026-08-14); 2.3x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 12.1M vs usual 5.9M (2026-07-31); 2.3x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 5.3M vs usual 1.3M (2025-09-30); 6.6x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 6.1M vs usual 1.2M (2025-09-15); 16.7x the same period a year earlier
25 Sep 20258-K and other filingsDirector or officer change
25 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Sep 2025Sharp changeShort interest spike: short interest spike, 5.3M vs usual 1.1M (2025-08-29); 10.4x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 5.5M vs usual 1.1M (2025-08-15); 9.5x the same period a year earlier
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 31 vs usual 6.50 (2025-06-30); 4.4x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 5.3M vs usual 922K (2025-07-31); 9.3x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 4.8M vs usual 752K (2025-07-15); 6.8x the same period a year earlier
3 Jun 2025Sharp changeShort interest spike: short interest spike, 1.8M vs usual 573K (2025-05-15); 6.2x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 1.6M vs usual 537K (2025-04-15); 4.4x the same period a year earlier
25 Apr 20258-K and other filingsChanged its auditor
15 Apr 2025Sharp changeShort interest spike: short interest spike, 1.4M vs usual 520K (2025-03-31); 3.1x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 1.2M vs usual 482K (2025-03-14); 5.3x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 1.8M vs usual 449K (2025-02-28); 8.8x the same period a year earlier
6 Dec 20248-K and other filingsPrivate placement of securities (Form D)
29 Nov 20248-K and other filingsA major agreement ended
12 Nov 20248-K and other filingsA major agreement ended
27 Aug 2024Sharp changeShort interest spike: short interest spike, 577K vs usual 172K (2024-08-15); 5.6x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 568K vs usual 143K (2024-07-31); 4.8x the same period a year earlier
30 Jul 2024Sharp changeShort interest spike: short interest spike, 700K vs usual 123K (2024-07-15); 5.9x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 755K vs usual 123K (2024-06-28); 5.0x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 594K vs usual 123K (2024-06-14); 4.2x the same period a year earlier
21 Jun 20248-K and other filingsDelisting notice or listing transfer
7 May 20248-K and other filingsDirector or officer change
7 May 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Nov 20238-K and other filingsDelisting notice or listing transfer
24 Nov 20238-K and other filingsDelisting notice or listing transfer
13 Nov 20238-K and other filingsDirector or officer change
13 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Nov 20238-K and other filingsPrivate placement of securities (Form D)
5 Apr 20238-K and other filingsPrivate placement of securities (Form D)
22 Mar 20238-K and other filingsPrivate placement of securities (Form D)
17 Feb 20238-K and other filingsA major agreement ended
2 Aug 20228-K and other filingsDirector or officer change
14 Jul 20228-K and other filingsRegistered new securities for sale (S-1)
22 Jun 20228-K and other filingsDirector or officer change
22 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jun 20228-K and other filingsRegistered new securities for sale (S-1)
1 Apr 20228-K and other filingsReport will be filed late
23 Mar 20228-K and other filingsDirector or officer change
3 Mar 20228-K and other filingsDirector or officer change
3 Mar 20228-K and other filingsCompleted an acquisition or asset sale
20 Jan 20228-K and other filingsDirector or officer change
20 Jan 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Sep 2022: -$58K published
Month from 1 Sep 2023: -$49K published
Month from 1 May 2025: $458K published
Month from 1 Aug 2025: $102K published
Month from 1 May 2026: $245K published
Revenue per quarter
Quarter ended 30 Sep 2021: $200K; public on 24 Nov 2021
Quarter ended 31 Dec 2021: $300K; public on 7 Apr 2022
Quarter ended 31 Mar 2022: $189K; public on 17 May 2022
Quarter ended 30 Sep 2022: $76K, -62% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $112K, -63% on a year earlier; public on 15 Mar 2023
Quarter ended 31 Mar 2023: $446K, +136% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $159K; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $783K, +930% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $1.0M, +829% on a year earlier; public on 26 Mar 2024
Quarter ended 31 Mar 2024: $1.0M, +124% on a year earlier; public on 14 May 2024
Quarter ended 30 Jun 2024: $976K, +514% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $1.2M, +50% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $1.2M, +15% on a year earlier; public on 25 Mar 2025
Quarter ended 31 Mar 2025: $828K, -17% on a year earlier; public on 14 May 2025
Quarter ended 30 Jun 2025: $1.2M, +19% on a year earlier; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $1.2M, +3.3% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $1.5M, +26% on a year earlier; public on 26 Mar 2026
Quarter ended 31 Mar 2026: $1.3M, +52% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $1.5M, +27% on a year earlier; public on 13 Aug 2026
Quarter ended 30 Sep 2026: $1.2M, -0.7% on a year earlier; public on 13 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2021: $9K; public on 17 May 2022
Quarter ended 30 Jun 2021: $1K; public on 16 Aug 2022
Quarter ended 30 Sep 2021: $28K; public on 24 Nov 2021
Quarter ended 31 Dec 2021: $824K; public on 7 Apr 2022
Quarter ended 31 Mar 2022: $148K, +1544% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $236K, +23500% on a year earlier; public on 16 Aug 2022
Quarter ended 30 Sep 2022: $321K, +1051% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Mar 2023: $17K, -89% on a year earlier; public on 16 May 2023
Quarter ended 31 Mar 2025: $93K; public on 14 May 2026
Quarter ended 30 Jun 2025: $25K; public on 13 Aug 2026
Quarter ended 30 Sep 2025: $28K; public on 13 Nov 2026
Quarter ended 31 Dec 2025: $51K; public on 26 Mar 2026
Quarter ended 31 Mar 2026: $215K, +131% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $21K, -16% on a year earlier; public on 13 Aug 2026
Quarter ended 30 Sep 2026: $17K, -39% on a year earlier; public on 13 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 32; public on 14 Feb 2022
31 Mar 2022 report: 31; public on 16 May 2022
30 Jun 2022 report: 29; public on 15 Aug 2022
30 Sep 2022 report: 19; public on 14 Nov 2022
31 Dec 2022 report: 22; public on 14 Feb 2023
31 Mar 2023 report: 18; public on 15 May 2023
30 Jun 2023 report: 16; public on 14 Aug 2023
30 Sep 2023 report: 21; public on 14 Nov 2023
31 Dec 2023 report: 21; public on 14 Feb 2024
31 Mar 2024 report: 27; public on 15 May 2024
30 Jun 2024 report: 32; public on 14 Aug 2024
30 Sep 2024 report: 27; public on 14 Nov 2024
31 Dec 2024 report: 31; public on 14 Feb 2025
31 Mar 2025 report: 46; public on 15 May 2025
30 Jun 2025 report: 68; public on 14 Aug 2025
30 Sep 2025 report: 79; public on 14 Nov 2025
31 Dec 2025 report: 87; public on 17 Feb 2026
31 Mar 2026 report: 98; public on 15 May 2026
30 Jun 2026 report: 113; public on 14 Aug 2026
30 Sep 2026 report: 113; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 12.8M shares sold short in the 14 Aug 2026 report, 2.3× the same report last year.
  • Short interest spike: had 12.1M shares sold short in the 31 Jul 2026 report, 2.3× the same report last year Public on 12 Aug 2026.
  • Insider net buying (open market): Insiders bought a net $245K in the last 12 months (the 12 months before: $560K).
  • Revenue per quarter: Revenue $1.2M in the latest quarter, -0.7% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 9 insider trades

No trades in the last 90 days; the latest was filed 21 May 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
21 May 2026Dennis MatheisDirectorBuy245,000$1.00$245KForm 4
22 Aug 2025Dennis MatheisDirectorBuy100,000$1.02$102KForm 4
22 May 2025Dennis MatheisDirectorBuy350,000$1.31$458KForm 4
27 Sep 2023Stanley LapidusDirectorSellplanned in advance (10b5-1)29,947$1.45$43KForm 4
22 Sep 2023Stanley LapidusDirectorSell3,917$1.45$6KForm 4
22 Sep 2022Stanley LapidusDirectorSell33,864$1.71$58KForm 4
20 Oct 2021PAVmed Inc.10% ownerBuy571,428$14.00$8.0MForm 4

113 institutions reported shares at the end of Q3 2026, 29% of the shares outstanding; 14 opened a position, 15 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.8.4M4.05%$6.3M+15K+0.2%
Alyeska Investment Group, L.P.8.0M3.85%$6.0M-887K-10%
Vanguard Capital Management LLC6.0M2.92%$4.5M-511K-7.8%
Two Seas Capital LP6.0M2.90%$4.5MNo change
Aberdeen Group plc4.4M2.14%$3.3M+597K+16%
Masters Capital Management LLC4.0M1.93%$3.0MNo change
Geode Capital Management, LLC3.6M1.72%$2.7M-224K-5.9%
Wells Fargo & Company2.5M1.23%$1.9M+469K+23%
State Street Corp2.4M1.18%$1.8M+4,883+0.2%
First Manhattan Co. LLC.2.2M1.06%$1.6MNo change

Company events

All 40 company events

In 12 months: 1 major agreement, 1 delisting notice. Results releases and routine reports are left out.

FiledWhat happenedSource
16 Oct 2026Delisting notice or listing transfer8-K
23 Apr 2026Signed a major agreement8-K
25 Sep 2025Director or officer change8-K
10 Sep 2025Signed a major agreement8-K
30 May 2025Signed a major agreement8-K
25 Apr 2025Changed its auditor8-K
10 Apr 2025Signed a major agreement8-K
4 Mar 2025Signed a major agreement8-K

The 5 newest of 94 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

14 Aug 2025confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Lucid Diagnostics (LUCD): had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year, while it saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year. Two unrelated kinds of activity within 77 days.

  • Short interest and volume: Short interest spike, became public on 25 Jul 2025
  • Short interest and volume: Short interest spike, became public on 12 Aug 2025
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
  • Short interest and volume: Short interest spike, became public on 27 Aug 2025
  • Short interest and volume: Short interest spike, became public on 11 Sep 2025
  • Short interest and volume: Short interest spike, became public on 25 Sep 2025
  • Short interest and volume: Short interest spike, became public on 10 Oct 2025
2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M
The 15 Jul 2025 report against the 24 reports before it. this reportearliernormal: 752K
See the evidence (7 changes)

Short interest and volume: Short interest spike became public on 25 Jul 2025

Lucid Diagnostics had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year.

This period
4.8M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
752K
Typical spread (median absolute deviation)
333K
How far from its usual level
+8.2
Same report last year
700K
History used
1,355 days
2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M
the 15 Jul 2025 report24 earlier reportsnormal: 752K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Aug 2025

Lucid Diagnostics had 5.3M shares sold short in the 31 Jul 2025 report, 9.3× the same report last year.

This period
5.3M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
922K
Typical spread (median absolute deviation)
467K
How far from its usual level
+6.3
Same report last year
568K
History used
1,371 days
2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M
the 31 Jul 2025 report24 earlier reportsnormal: 922K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

Lucid Diagnostics saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year.

This period
31 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
6.5
Typical spread (median absolute deviation)
3.5
How far from its usual level
+4.7
Same quarter last year
7
History used
1,277 days
2023-06-30: 22023-09-30: 62023-12-31: 22024-03-31: 82024-06-30: 72024-09-30: 22024-12-31: 92025-03-31: 182025-06-30: 31
the quarter ended 30 Jun 20258 earlier quartersnormal: 6.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 27 Aug 2025

Lucid Diagnostics had 5.5M shares sold short in the 15 Aug 2025 report, 9.5× the same report last year.

This period
5.5M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
575K
How far from its usual level
+5.2
Same report last year
577K
History used
1,386 days
2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M
the 15 Aug 2025 report24 earlier reportsnormal: 1.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Sep 2025

Lucid Diagnostics had 5.3M shares sold short in the 29 Aug 2025 report, 10× the same report last year.

This period
5.3M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
614K
How far from its usual level
+4.6
Same report last year
507K
History used
1,400 days
2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M
the 29 Aug 2025 report24 earlier reportsnormal: 1.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Sep 2025

Lucid Diagnostics had 6.1M shares sold short in the 15 Sep 2025 report, 17× the same report last year.

This period
6.1M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
634K
How far from its usual level
+5.2
Same report last year
363K
History used
1,417 days
2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M
the 15 Sep 2025 report24 earlier reportsnormal: 1.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Oct 2025

Lucid Diagnostics had 5.3M shares sold short in the 30 Sep 2025 report, 6.6× the same report last year.

This period
5.3M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
740K
How far from its usual level
+3.7
Same report last year
804K
History used
1,432 days
2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M2025-09-30: 5.3M
the 30 Sep 2025 report24 earlier reportsnormal: 1.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 16 Oct 2026Filings record

    Delisting notice or listing transfer

  2. 26 Aug 2026Short interest and volume change

    had 12.8M shares sold short in the 14 Aug 2026 report, 2.3× the same report last year.

    Same report last year: 5.5M; its normal report is 5.9M.

    See the evidence
    This period
    12.8M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    5.9M
    Typical spread (median absolute deviation)
    1.1M
    How far from its usual level
    +4.1
    Same report last year
    5.5M
    History used
    1,750 days
    2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M2025-09-30: 5.3M2025-10-15: 3.7M2025-10-31: 2.9M2025-11-14: 3.0M2025-11-28: 3.9M2025-12-15: 4.3M2025-12-31: 4.7M2026-01-15: 3.8M2026-01-30: 7.0M2026-02-13: 7.3M2026-02-27: 6.7M2026-03-13: 5.8M2026-03-31: 5.9M2026-04-15: 6.2M2026-04-30: 5.9M2026-05-15: 6.6M2026-05-29: 6.1M2026-06-15: 7.4M2026-06-30: 9.4M2026-07-15: 10.9M2026-07-31: 12.1M2026-08-14: 12.8M
    the 14 Aug 2026 report24 earlier reportsnormal: 5.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 12 Aug 2026Short interest and volume change

    had 12.1M shares sold short in the 31 Jul 2026 report, 2.3× the same report last year.

    Same report last year: 5.3M; its normal report is 5.9M.

    See the evidence
    This period
    12.1M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    5.9M
    Typical spread (median absolute deviation)
    990K
    How far from its usual level
    +4.3
    Same report last year
    5.3M
    History used
    1,736 days
    2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M2025-09-30: 5.3M2025-10-15: 3.7M2025-10-31: 2.9M2025-11-14: 3.0M2025-11-28: 3.9M2025-12-15: 4.3M2025-12-31: 4.7M2026-01-15: 3.8M2026-01-30: 7.0M2026-02-13: 7.3M2026-02-27: 6.7M2026-03-13: 5.8M2026-03-31: 5.9M2026-04-15: 6.2M2026-04-30: 5.9M2026-05-15: 6.6M2026-05-29: 6.1M2026-06-15: 7.4M2026-06-30: 9.4M2026-07-15: 10.9M2026-07-31: 12.1M
    the 31 Jul 2026 report24 earlier reportsnormal: 5.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 22 May 2026Insiders record

    Matheis Dennis (director) bought 245,000 shares of LUCD ($245,000) (dated 21 May 2026)

  5. 10 Oct 2025Short interest and volume change

    had 5.3M shares sold short in the 30 Sep 2025 report, 6.6× the same report last year.

    Same report last year: 804K; its normal report is 1.3M.

    See the evidence
    This period
    5.3M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    740K
    How far from its usual level
    +3.7
    Same report last year
    804K
    History used
    1,432 days
    2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M2025-09-30: 5.3M
    the 30 Sep 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 25 Sep 2025Short interest and volume change

    had 6.1M shares sold short in the 15 Sep 2025 report, 17× the same report last year.

    Same report last year: 363K; its normal report is 1.2M.

    See the evidence
    This period
    6.1M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    634K
    How far from its usual level
    +5.2
    Same report last year
    363K
    History used
    1,417 days
    2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M
    the 15 Sep 2025 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 25 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 25 Sep 2025Filings record

    Director or officer change

  9. 11 Sep 2025Short interest and volume change

    had 5.3M shares sold short in the 29 Aug 2025 report, 10× the same report last year.

    Same report last year: 507K; its normal report is 1.1M.

    See the evidence
    This period
    5.3M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    614K
    How far from its usual level
    +4.6
    Same report last year
    507K
    History used
    1,400 days
    2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M
    the 29 Aug 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 27 Aug 2025Short interest and volume change

    had 5.5M shares sold short in the 15 Aug 2025 report, 9.5× the same report last year.

    Same report last year: 577K; its normal report is 1.1M.

    See the evidence
    This period
    5.5M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    575K
    How far from its usual level
    +5.2
    Same report last year
    577K
    History used
    1,386 days
    2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M
    the 15 Aug 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 23 Aug 2025Insiders record

    Matheis Dennis (director) bought 100,000 shares of LUCD ($102,000) (dated 22 Aug 2025)

  12. 14 Aug 2025several at once

    had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year, while it saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year. Two unrelated kinds of activity within 77 days.

    See the evidence (7 changes)

    Short interest and volume: Short interest spike became public on 25 Jul 2025

    Lucid Diagnostics had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year.

    This period
    4.8M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    752K
    Typical spread (median absolute deviation)
    333K
    How far from its usual level
    +8.2
    Same report last year
    700K
    History used
    1,355 days
    2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M
    the 15 Jul 2025 report24 earlier reportsnormal: 752K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Aug 2025

    Lucid Diagnostics had 5.3M shares sold short in the 31 Jul 2025 report, 9.3× the same report last year.

    This period
    5.3M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    922K
    Typical spread (median absolute deviation)
    467K
    How far from its usual level
    +6.3
    Same report last year
    568K
    History used
    1,371 days
    2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M
    the 31 Jul 2025 report24 earlier reportsnormal: 922K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

    Lucid Diagnostics saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year.

    This period
    31 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    6.5
    Typical spread (median absolute deviation)
    3.5
    How far from its usual level
    +4.7
    Same quarter last year
    7
    History used
    1,277 days
    2023-06-30: 22023-09-30: 62023-12-31: 22024-03-31: 82024-06-30: 72024-09-30: 22024-12-31: 92025-03-31: 182025-06-30: 31
    the quarter ended 30 Jun 20258 earlier quartersnormal: 6.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 27 Aug 2025

    Lucid Diagnostics had 5.5M shares sold short in the 15 Aug 2025 report, 9.5× the same report last year.

    This period
    5.5M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    575K
    How far from its usual level
    +5.2
    Same report last year
    577K
    History used
    1,386 days
    2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M
    the 15 Aug 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Sep 2025

    Lucid Diagnostics had 5.3M shares sold short in the 29 Aug 2025 report, 10× the same report last year.

    This period
    5.3M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    614K
    How far from its usual level
    +4.6
    Same report last year
    507K
    History used
    1,400 days
    2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M
    the 29 Aug 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Sep 2025

    Lucid Diagnostics had 6.1M shares sold short in the 15 Sep 2025 report, 17× the same report last year.

    This period
    6.1M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    634K
    How far from its usual level
    +5.2
    Same report last year
    363K
    History used
    1,417 days
    2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M
    the 15 Sep 2025 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Oct 2025

    Lucid Diagnostics had 5.3M shares sold short in the 30 Sep 2025 report, 6.6× the same report last year.

    This period
    5.3M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    740K
    How far from its usual level
    +3.7
    Same report last year
    804K
    History used
    1,432 days
    2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M2025-08-15: 5.5M2025-08-29: 5.3M2025-09-15: 6.1M2025-09-30: 5.3M
    the 30 Sep 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  13. 14 Aug 2025Institutional holdings change

    saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year.

    Same quarter last year: 7; its normal quarter is 6.5.

    See the evidence
    This period
    31 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    6.5
    Typical spread (median absolute deviation)
    3.5
    How far from its usual level
    +4.7
    Same quarter last year
    7
    History used
    1,277 days
    2023-06-30: 22023-09-30: 62023-12-31: 22024-03-31: 82024-06-30: 72024-09-30: 22024-12-31: 92025-03-31: 182025-06-30: 31
    the quarter ended 30 Jun 20258 earlier quartersnormal: 6.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  14. 12 Aug 2025Short interest and volume change

    had 5.3M shares sold short in the 31 Jul 2025 report, 9.3× the same report last year.

    Same report last year: 568K; its normal report is 922K.

    See the evidence
    This period
    5.3M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    922K
    Typical spread (median absolute deviation)
    467K
    How far from its usual level
    +6.3
    Same report last year
    568K
    History used
    1,371 days
    2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 5.3M
    the 31 Jul 2025 report24 earlier reportsnormal: 922K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 25 Jul 2025Short interest and volume change

    had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year.

    Same report last year: 700K; its normal report is 752K.

    See the evidence
    This period
    4.8M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    752K
    Typical spread (median absolute deviation)
    333K
    How far from its usual level
    +8.2
    Same report last year
    700K
    History used
    1,355 days
    2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M2025-05-30: 1.1M2025-06-13: 1.7M2025-06-30: 4.9M2025-07-15: 4.8M
    the 15 Jul 2025 report24 earlier reportsnormal: 752K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 28 May 2025Short interest and volume change

    had 1.8M shares sold short in the 15 May 2025 report, 6.2× the same report last year.

    Same report last year: 285K; its normal report is 573K.

    See the evidence
    This period
    1.8M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    573K
    Typical spread (median absolute deviation)
    221K
    How far from its usual level
    +3.7
    Same report last year
    285K
    History used
    1,294 days
    2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M2025-04-30: 1.3M2025-05-15: 1.8M
    the 15 May 2025 report24 earlier reportsnormal: 573K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 24 May 2025Insiders record

    Matheis Dennis (director) bought 350,000 shares of LUCD ($458,258) [amended] (dated 23 May 2025)

  18. 23 May 2025Insiders record

    Matheis Dennis (director) bought 350,000 shares of LUCD ($458,258) (dated 22 May 2025)

  19. 26 Apr 2025Short interest and volume change

    had 1.6M shares sold short in the 15 Apr 2025 report, 4.4× the same report last year.

    Same report last year: 361K; its normal report is 537K.

    See the evidence
    This period
    1.6M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    537K
    Typical spread (median absolute deviation)
    175K
    How far from its usual level
    +4.1
    Same report last year
    361K
    History used
    1,264 days
    2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M2025-04-15: 1.6M
    the 15 Apr 2025 report24 earlier reportsnormal: 537K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 25 Apr 2025Filings record

    Changed its auditor

  21. 10 Apr 2025Short interest and volume change

    had 1.4M shares sold short in the 31 Mar 2025 report, 3.1× the same report last year.

    Same report last year: 441K; its normal report is 520K.

    See the evidence
    This period
    1.4M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    520K
    Typical spread (median absolute deviation)
    157K
    How far from its usual level
    +3.6
    Same report last year
    441K
    History used
    1,249 days
    2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M2025-03-31: 1.4M
    the 31 Mar 2025 report24 earlier reportsnormal: 520K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 26 Mar 2025Short interest and volume change

    had 1.2M shares sold short in the 14 Mar 2025 report, 5.3× the same report last year.

    Same report last year: 231K; its normal report is 482K.

    See the evidence
    This period
    1.2M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    482K
    Typical spread (median absolute deviation)
    119K
    How far from its usual level
    +4.2
    Same report last year
    231K
    History used
    1,232 days
    2024-03-15: 231K2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M2025-03-14: 1.2M
    the 14 Mar 2025 report24 earlier reportsnormal: 482K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 12 Mar 2025Short interest and volume change

    had 1.8M shares sold short in the 28 Feb 2025 report, 8.8× the same report last year.

    Same report last year: 203K; its normal report is 449K.

    See the evidence
    This period
    1.8M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    449K
    Typical spread (median absolute deviation)
    118K
    How far from its usual level
    +7.7
    Same report last year
    203K
    History used
    1,218 days
    2024-02-29: 203K2024-03-15: 231K2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K2024-08-30: 507K2024-09-13: 363K2024-09-30: 804K2024-10-15: 1.1M2024-10-31: 422K2024-11-15: 293K2024-11-29: 422K2024-12-13: 333K2024-12-31: 434K2025-01-15: 542K2025-01-31: 533K2025-02-14: 1.0M2025-02-28: 1.8M
    the 28 Feb 2025 report24 earlier reportsnormal: 449K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 6 Dec 2024Filings record

    Private placement of securities (Form D)

  25. 29 Nov 2024Filings record

    A major agreement ended

  26. 12 Nov 2024Filings record

    A major agreement ended

  27. 27 Aug 2024Short interest and volume change

    had 577K shares sold short in the 15 Aug 2024 report, 5.6× the same report last year.

    Same report last year: 102K; its normal report is 172K.

    See the evidence
    This period
    577K (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    172K
    Typical spread (median absolute deviation)
    73K
    How far from its usual level
    +3.8
    Same report last year
    102K
    History used
    1,021 days
    2023-08-15: 102K2023-08-31: 87K2023-09-15: 99K2023-09-29: 99K2023-10-13: 97K2023-10-31: 109K2023-11-15: 119K2023-11-30: 120K2023-12-15: 159K2023-12-29: 119K2024-01-12: 109K2024-01-31: 127K2024-02-15: 185K2024-02-29: 203K2024-03-15: 231K2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K2024-07-31: 568K2024-08-15: 577K
    the 15 Aug 2024 report24 earlier reportsnormal: 172K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 10 Aug 2024Short interest and volume change

    had 568K shares sold short in the 31 Jul 2024 report, 4.8× the same report last year.

    Same report last year: 117K; its normal report is 143K.

    See the evidence
    This period
    568K (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    143K
    Typical spread (median absolute deviation)
    45K
    How far from its usual level
    +6.4
    Same report last year
    117K
    History used
    1,006 days
    2023-07-31: 117K2023-08-15: 102K2023-08-31: 87K2023-09-15: 99K2023-09-29: 99K2023-10-13: 97K2023-10-31: 109K2023-11-15: 119K2023-11-30: 120K2023-12-15: 159K2023-12-29: 119K2024-01-12: 109K2024-01-31: 127K2024-02-15: 185K2024-02-29: 203K2024-03-15: 231K2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K2024-07-31: 568K
    the 31 Jul 2024 report24 earlier reportsnormal: 143K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 25 Jul 2024Short interest and volume change

    had 700K shares sold short in the 15 Jul 2024 report, 5.9× the same report last year.

    Same report last year: 119K; its normal report is 123K.

    See the evidence
    This period
    700K (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    123K
    Typical spread (median absolute deviation)
    31K
    How far from its usual level
    +11.5
    Same report last year
    119K
    History used
    990 days
    2023-07-14: 119K2023-07-31: 117K2023-08-15: 102K2023-08-31: 87K2023-09-15: 99K2023-09-29: 99K2023-10-13: 97K2023-10-31: 109K2023-11-15: 119K2023-11-30: 120K2023-12-15: 159K2023-12-29: 119K2024-01-12: 109K2024-01-31: 127K2024-02-15: 185K2024-02-29: 203K2024-03-15: 231K2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K2024-07-15: 700K
    the 15 Jul 2024 report24 earlier reportsnormal: 123K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 11 Jul 2024Short interest and volume change

    had 755K shares sold short in the 28 Jun 2024 report, 5.0× the same report last year.

    Same report last year: 150K; its normal report is 123K.

    See the evidence
    This period
    755K (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    123K
    Typical spread (median absolute deviation)
    27K
    How far from its usual level
    +12.6
    Same report last year
    150K
    History used
    973 days
    2023-06-30: 150K2023-07-14: 119K2023-07-31: 117K2023-08-15: 102K2023-08-31: 87K2023-09-15: 99K2023-09-29: 99K2023-10-13: 97K2023-10-31: 109K2023-11-15: 119K2023-11-30: 120K2023-12-15: 159K2023-12-29: 119K2024-01-12: 109K2024-01-31: 127K2024-02-15: 185K2024-02-29: 203K2024-03-15: 231K2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K2024-06-28: 755K
    the 28 Jun 2024 report24 earlier reportsnormal: 123K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 27 Jun 2024Short interest and volume change

    had 594K shares sold short in the 14 Jun 2024 report, 4.2× the same report last year.

    Same report last year: 142K; its normal report is 123K.

    See the evidence
    This period
    594K (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    123K
    Typical spread (median absolute deviation)
    25K
    How far from its usual level
    +9.4
    Same report last year
    142K
    History used
    959 days
    2023-06-15: 142K2023-06-30: 150K2023-07-14: 119K2023-07-31: 117K2023-08-15: 102K2023-08-31: 87K2023-09-15: 99K2023-09-29: 99K2023-10-13: 97K2023-10-31: 109K2023-11-15: 119K2023-11-30: 120K2023-12-15: 159K2023-12-29: 119K2024-01-12: 109K2024-01-31: 127K2024-02-15: 185K2024-02-29: 203K2024-03-15: 231K2024-03-28: 441K2024-04-15: 361K2024-04-30: 457K2024-05-15: 285K2024-05-31: 331K2024-06-14: 594K
    the 14 Jun 2024 report24 earlier reportsnormal: 123K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 21 Jun 2024Filings record

    Delisting notice or listing transfer

  33. 7 May 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 7 May 2024Filings record

    Director or officer change

  35. 28 Nov 2023Filings record

    Delisting notice or listing transfer

  36. 24 Nov 2023Filings record

    Delisting notice or listing transfer

  37. 13 Nov 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 13 Nov 2023Filings record

    Director or officer change

  39. 1 Nov 2023Filings record

    Private placement of securities (Form D)

  40. 5 Apr 2023Filings record

    Private placement of securities (Form D)

Showing the newest 40 of 58 entries; narrow the window or the kind of data to see older ones.

Not listed: 64 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001799011
Ticker
LUCD
Domain
luciddx.com
Hq location
NY|NEW YORK|10017 (1 unverified)
Name
CapNostics LLC (84-4876240), Lucid Diagnostics Inc., LucidDx Labs Inc. (87-41661458), Wholly-Owned Subsidiary of Lucid Diagnostics Inc
  • SEC Form 13F institutional holdings180 data points31 Dec 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)88 records22 Sep 2021 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)360 data points31 Dec 2019 to 10 Nov 2026
  • SEC Form 4 insider transactions9 records, 28 data points20 Oct 2021 to 21 May 2026
  • FINRA short interest (twice monthly)359 data points29 Oct 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2564 data points14 Oct 2021 to 20 Nov 2026